Management: When used at chemotherapy doses, hold blood pressure lowering medications for 24 hours before amifostine administration. Also, lying down for a while may relieve dizziness or lightheadedness. Your instincts were correct. However, generally speaking, most information reviewed about Metoprolol includes the caveat that when it is administered IV, the patient should be monitored carefully by EKG, BP readings and heart rate. Tell your doctor right away if you are having chest pain or discomfort, dilated neck veins, extreme fatigue, irregular breathing, an irregular heartbeat, shortness of breath, swelling of the face, fingers, feet, or lower legs, weight gain, or wheezing. Consider therapy modification, Cholinergic Agonists: Beta-Blockers may enhance the adverse/toxic effect of Cholinergic Agonists. Monitor patients for bradycardia. Monitor therapy, White Birch Allergen Extract: Beta-Blockers may enhance the adverse/toxic effect of White Birch Allergen Extract. A 10 mg/mL oral suspension may be made with metoprolol tartrate tablets and one of three different vehicles (cherry syrup; a 1:1 mixture of Ora-Sweet and Ora-Plus; or a 1:1 mixture of Ora-Sweet SF and Ora-Plus). Consider therapy modification, DULoxetine: Blood Pressure Lowering Agents may enhance the hypotensive effect of DULoxetine. METOPROLOL (Lopressor R) Classification: beta 1 and beta 2 selective receptor blocker. Monitor therapy, Nicorandil: May enhance the hypotensive effect of Blood Pressure Lowering Agents. If angina markedly worsens or acute coronary insufficiency develops, reinstate metoprolol administration promptly, at least temporarily, and take other measures appropriate for the management of unstable angina. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. of selected IV push medications (e.g., age, metric height and weight, laboratory values) Risks Associated with Lack of Drug Information • A frequent lack of direction for the rate of IV push administration from drug information resources (either because the reference does not indicate if there is a rate for administration or it uses ambiguous terminology such as IV push, IV bolus, … Patients who did not receive a beta-blocker within 24 hours of myocardial infarction should be reevaluated for secondary prevention at a later date. 5 Anwendungsgebiete. She had taken 4 … Metoprolol is a selective β1 receptor blocker used in the treatment of cardiovascular disease. A beta-blocker is also used to reduce shocks in patients who receive an implantable cardioverter defibrillator for these indications (AHA/ACC/HRS [Al-Khatib 2017]); propranolol may be the preferred beta-blocker in these situations (Chatzidou 2018). Getting up slowly may help lessen this problem. • Atrioventricular (AV) block: Metoprolol commonly produces mild first-degree heart block. Therefore, patient variability may exist and a specific ratio may not apply to all patients, especially if comorbid conditions are present. Management: Avoid the concomitant use of fingolimod and beta-blockers if possible. Beta-Blockers may enhance the negative inotropic effect of Disopyramide. Online ahead of print. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements. Monitor therapy, Lacosamide: Bradycardia-Causing Agents may enhance the AV-blocking effect of Lacosamide. Peginterferon Alfa-2b may increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). This medicine may cause changes in your blood sugar levels. 1 Name of Medicine. Lopressor Injection (metoprolol tartrate) is a selective beta1-adrenoreceptor blocking agent (beta-blocker) indicated for the treatment of hypertension.Lopressor Injection may be used alone or in combination with other antihypertensive agents. In the management of hypertension, consider lower initial doses and titrate to response (Aronow 2011). Metoprolol injection is used to reduce the risk of death from an acute heart attack. Atrial fibrillation (AF) is the most commonly encountered cardiac dysrhythmia in emergency departments (EDs) in the United States; it is the reason for more than 500,000 ED visits each year.1 Two approaches to the treatment of AF in the ED are rhythm control, including cardioversion and antiarrhythmic drug therapy, and rate control using atrioventricular nodal-blocking agents.2 Guidelines issued in 2014 by the American Heart Association (AHA), America… Actual fetal/neonatal risks may be related to duration and severity of maternal hypertension. Each ampul contains a sterile solution of metoprolol tartrate USP, 5 mg, and sodium chloride USP, 45 mg, and water for injection USP. • Peripheral vascular disease (PVD) and Raynaud disease: May precipitate or aggravate symptoms of arterial insufficiency in patients with PVD and Raynaud disease. Angina: Long-term treatment of angina pectoris. Metoprolol tartrate. Select one or more newsletters to continue. Nurses Nursing. • Major surgery: Chronic beta-blocker therapy should not be routinely withdrawn prior to major surgery. Syncope, vagal: Limited data available: Children ≥7 years and Adolescents: Tilt-table test: IV: 0.1 to 0.2 mg/kg; maximum dose: 10 mg/dose (Muller 1993, O'Marcaigh 1994). Note: Initiate cautiously in patients with concomitant heart failure. IR tablet, oral solution, and injectable formulations are available. This medicine may cause some people to become less alert than they are normally. Don't delay your care at Mayo Clinic. Monitor therapy, Alpha1-Blockers: Beta-Blockers may enhance the orthostatic hypotensive effect of Alpha1-Blockers. The peak effect of IV-push metoprolol occurs between 5 and 10 min after administration. Beta-Blockers may enhance the rebound hypertensive effect of Alpha2-Agonists. Dangerous IV Push Medication Practices Earlier this year, the Institute for Safe Medication Practices (ISMP) conducted a follow-up survey to three prior surveys that uncovered many dangerous intravenous (IV) push medication administration practices among clinicians. Monitor therapy, Quinagolide: May enhance the hypotensive effect of Blood Pressure Lowering Agents. Monitor therapy, Dexmethylphenidate: May diminish the therapeutic effect of Antihypertensive Agents. Metoprolol may also produce severe first-, second-, or third-degree heart block. Metoprolol Tartrate Injection, USP vials are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used in conjunction with oral metoprolol maintenance therapy. Recognizing that patients receiving larger chronic oral doses should not automatically be converted to a large IV dose, consideration should be given to further reducing the initial IV dose and basing subsequent doses on the clinical response (Huckleberry 2003). In my hospital, even in the ICU, we only push metoprolol in an emergency (they must be on the monitor and a provider must push it). administering metoprolol iv. Some institutions require monitoring of baseline and postinfusion heart rate and blood pressure when a patient's response to beta-blockade has not been characterized (ie, the patient's initial dose or following a change in dose). Monitor therapy, Bromperidol: Blood Pressure Lowering Agents may enhance the hypotensive effect of Bromperidol. Monitor therapy, Beta2-Agonists: Beta-Blockers (Beta1 Selective) may diminish the bronchodilatory effect of Beta2-Agonists. This content does not have an English version. The estimated equivalent IV total daily dose should be divided into 4 equal doses. Supraventricular tachycardia (eg, atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, focal atrial tachycardia, multifocal atrial tachycardia) (off-label use): Note: Consider for hemodynamically stable patients if vagal maneuvers and/or adenosine are unsuccessful. J Clin Pharmacol, 1990, 30(2 Suppl), S57-60 Pubmed ; Koch-Weser J. Metoprolol 5 mg IV push x1 now The administration of a beta blocker will work to decrease BP, contractility, decrease the HR, and reduce oxygen consumption of the heart … Untreated chronic hypertension may also increase the risks of adverse maternal outcomes, including gestational diabetes, preeclampsia, delivery complications, stroke, and myocardial infarction (ACOG 203 2019). Monitor therapy, NIFEdipine: May enhance the hypotensive effect of Beta-Blockers. Dangerous IV Push Medication Practices Earlier this year, the Institute for Safe Medication Practices (ISMP) conducted a follow-up survey to three prior surveys that uncovered many dangerous intravenous (IV) push medication administration practices among clinicians. In patients who tolerate the full intravenous dose (15 mg), metoprolol tartrate tablets, 50 mg every 6 hours, should be initiated 15 minutes after the last intravenous dose and continued for 48 hours. It works by affecting the response to nerve impulses in certain parts of the body, like the heart. For these types of SVT enhanced antegrade conduction from atria to ventricles may occur through an accessory pathway leading to ventricular arrhythmias if the AV node is blocked. Intravenous push (IVP) diltiazem and metoprolol are commonly used for the acute management of AF with RVR in the ED. In patients without pre-excitation, intravenous metoprolol is recommended for acute treatment in hemodynamically stable patients and oral metoprolol is recommended for ongoing management of symptomatic supraventricular tachycardias in patients who are not candidates for, or prefer not to undergo, catheter ablation. Schedule your appointment now for safe in-person care. Monitor therapy, Bradycardia-Causing Agents: May enhance the bradycardic effect of other Bradycardia-Causing Agents. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect: • Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat. Bariatric surgery: Some institutions may have specific protocols that conflict with these recommendations; refer to institutional protocols as appropriate. School Mercy College of Health Science; Course Title NUR MISC; Uploaded By PrivateFog10912. Temporary but prompt resumption of beta-blocker therapy may be indicated with worsening of angina or acute coronary insufficiency. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. Immediate release (metoprolol tartrate): Administer with or immediately following meals. Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away: WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Monitor therapy, Amiodarone: May enhance the bradycardic effect of Beta-Blockers. Monitor therapy, Naftopidil: May enhance the hypotensive effect of Blood Pressure Lowering Agents. This effect can occur when the Alpha2-Agonist is abruptly withdrawn. Lopressor Injection is also indicated in the long-term treatment of angina pectoris, and in the treatment of … Avoid combination, Grass Pollen Allergen Extract (5 Grass Extract): Beta-Blockers may enhance the adverse/toxic effect of Grass Pollen Allergen Extract (5 Grass Extract). Add 20 mL of the chosen vehicle and mix to a uniform paste; mix while adding the vehicle in incremental proportions to almost 120 mL; transfer to a calibrated bottle, rinse mortar with vehicle, and add quantity of vehicle sufficient to make 120 mL. • A frequent lack of direction for the rate of IV push administration from drug information resources (either because the reference does not indicate if there is a rate for administration or it uses ambiguous terminology such as IV push, IV bolus, “slow” or “fast” IV push, leading to … Use with caution and monitor for progression of arterial obstruction. Based on evidence-based guidelines for pharmacologic treatment for episodic migraine prevention in adults from the American Academy of Neurology and the American Headache Society, metoprolol is effective for migraine prevention in adults. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue metoprolol therapy abruptly, even in patients treated only for hypertension. Monitor therapy, Benperidol: May enhance the hypotensive effect of Blood Pressure Lowering Agents. • Elderly: Bradycardia may be observed more frequently in elderly patients (>65 years of age); dosage reductions may be necessary. Switching between oral and intravenous dosage forms: In most cases, equivalent beta-blocking effect is achieved when a 2.5:1 (Oral:IV) ratio is used. Amiodarone may increase the serum concentration of Beta-Blockers. Poor CYP2D6 metabolizers (~8% Caucasians; ~2% other populations) have several-fold higher metoprolol plasma concentrations. Based on the American College of Cardiology/American Heart Association/Heart Rhythm Society (ACC/AHA/HRS) guidelines for the management of adult patients with supraventricular tachycardia, the use of an oral or intravenous beta-blocker, including metoprolol, is effective and recommended for a variety of symptomatic supraventricular tachycardias (atrioventricular nodal reentrant tachycardia [AVNRT], atrioventricular reentrant tachycardia [AVRT], focal atrial tachycardia [AT], and multifocal atrial tachycardia [MAT]). Metoprolol Tartrate vs Succinate - What's the difference between them? Monitor therapy, Obinutuzumab: May enhance the hypotensive effect of Blood Pressure Lowering Agents. Recommendations for other alpha2-agonists are unavailable. Bromperidol may diminish the hypotensive effect of Blood Pressure Lowering Agents. The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Metoprolol: Der Wirkstoff senkt den Blutdruck. ... 2.5-5mg IV direct q2-5min as IV push to a maximum of 15 mg over 15 minutes; Intermittent bolus: 5-15mg IV direct q4-8h; ... May be administed IV direct or by IV infusion by a nurse in Adult Critical Care; Females with preexisting hypertension may continue their medication during pregnancy unless contraindications exist (ESC [Regitz-Zagrosek 2018]). BRAND INFORMATION. T1 - Intravenous Metoprolol Versus Diltiazem for Rate Control in Noncardiac, Nonthoracic Postoperative Atrial Fibrillation. Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic School of Continuous Professional Development, Mayo Clinic School of Graduate Medical Education, FREE book offer — Mayo Clinic Health Letter, Time running out - 40% off Online Mayo Clinic Diet ends soon. 5 mg IV direct q2min x 3 doses; Atrial Fibrillation: 2.5-5mg IV direct q2-5min as IV push to a maximum of 15 mg over 15 minutes; Intermittent bolus: 5-15mg IV direct q4-8h; Adverse Effects: bradycardia; AV blocks; hypotension ; decreased cardiac output; bronchospasm; acute pulmonary edema; electrolyte imbalances; may mask tremors and tachycardia associated with insulin … Consider therapy modification, Floctafenine: May enhance the adverse/toxic effect of Beta-Blockers. Monitor therapy, Theophylline Derivatives: Beta-Blockers (Beta1 Selective) may diminish the bronchodilatory effect of Theophylline Derivatives. Immediate release (metoprolol tartrate): Oral: 25 to 100 mg twice daily (AHA/ACC/HRS [January 2014]); more frequent dosing is appropriate in the acute setting while titrating to a maintenance dose. Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction (MI) have occurred. Management: Avoid coadministration of siponimod with drugs that may cause bradycardia. Monitor therapy, Propafenone: May increase the serum concentration of Beta-Blockers. Avoid in patients with decompensated heart failure (electrical cardioversion preferred) (ACC/AHA/HRS [Page 2016]; AHA [Neumar 2010]). Our general interest e-newsletter keeps you up to date on a wide variety of health topics. Copyright © 2021 IBM Watson Health. Gently shake the syringe for ~10 seconds. Mayo Clinic does not endorse companies or products. N Engl J Med, 1979, 301(13), 698-703 Pubmed ; Autor. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. Note: Small doses of IV metoprolol at the time of presentation may be considered for ST-elevation myocardial infarction (STEMI) patients with hypertension or ongoing ischemia if no contraindications exist. • Switching dosage forms: The conversion ratio for immediate release (metoprolol tartrate) and extended release (metoprolol succinate) is 1:1, therefore the same total daily dose of metoprolol should be used when switching formulations. Patients with first-degree AV block, sinus node dysfunction, or conduction disorders may be at increased risk. SPECIAL CONSIDERATIONS IV metoprolol may be given by direct IV undiluted at a rate of 5mg over 2-5 minutes DOSING REGIMEN Adult: 5mg Slow IV push over 2-5 mins May repeat every 5 minutes to max of 15 mg. Talk to your doctor if you have questions. However, because of similarities in chemical structure and/or pharmacologic actions, the possibility of cross-sensitivity cannot be ruled out with certainty. • Abrupt withdrawal: [US Boxed Warning]: Beta-blocker therapy should not be withdrawn abruptly (particularly in patients with CAD), but gradually tapered over 1 to 2 weeks to avoid acute tachycardia, hypertension, and/or ischemia. Metoprolol wird angewandt bei der Behandlung des Bluthochdrucks, der keine organischen Ursachen hat (essentieller Bluthochdruck), und bei Herz- und Kreislaufbeschwerden. The pharmacokinetics of metoprolol may be changed during pregnancy; the degree of changes may be dependent upon maternal CYP2D6 genotype (Ryu 2016). AU - Oyen, Lance J. PY - 2014/3/1. Lopressor, metoprolol tartrate USP, is a selective betai-adrenoreceptor blocking agent, available in 5-mL ampuls for intravenous administration. PRECAUTIONS During IV administration, BP, heart rate, and ECG should be carefully monitored. Myocardial infarction: Treatment of hemodynamically stable acute myocardial infarction to reduce cardiovascular mortality (injection to be used in combination with metoprolol oral maintenance therapy). I had the nitro ready to go once the metoprolol was in. Avoid combination, Fingolimod: Beta-Blockers may enhance the bradycardic effect of Fingolimod. Note: For control of cardiovascular effects until euthyroidism established (ATA [Ross 2016]). Initial: 5 mg; repeat dose every 5 minutes for up to 3 doses as needed based on heart rate and blood pressure; maximum total dose: 15 mg; begin oral therapy 15 to 30 minutes after the last IV dose (ACCF/AHA [O'Gara 2013]; Chen 2005; Rosenson 2018). While the latest survey found a decrease in some of the risky practices, many 10 mg/mL Oral Suspension (ASHP Standard Concentration) (ASHP 2017). • Supraventricular tachycardia (SVT): If antidromic atrioventricular reentrant tachycardia (AVRT) or pre-excited atrial fibrillation is suspected, avoid AV node-specific blocking drugs (eg, adenosine, diltiazem, verapamil, digoxin, beta-blockers). Atrial Fibrillation/Flutter or Supraventricular Tachycardia (Off-label) 2.5-5 mg IV q2-5min; not to exceed 15 mg over 10-15 minutes; maintenance: 25-100 mg PO q12hr. We comply with the HONcode standard for trustworthy health information -, American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guideline for the management of patients with atrial fibrillation, American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guideline for coronary artery bypass graft surgery, American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guideline for the diagnosis and treatment of hypertrophic cardiomyopathy, American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery (ACCF/AHA/AATS) guideline for the diagnosis and management of patients with thoracic aortic disease, evidence-based guidelines for pharmacologic treatment for episodic migraine prevention in adults from the American Academy of Neurology and the American Headache Society, American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Monitor therapy, Ajmaline: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Atrial fibrillation prevention after cardiac surgery: Note: Initiate prior to surgery (preferentially at least 48 hours before) or postoperatively when hemodynamically stable. Hypertension: Note: Guidelines do not recommend beta-blockers as initial therapy in pediatric patients; beta-blockers should be reserved for use in patients who have contraindications to preferred agents or after ≥2 preferred agents have failed in patients with hypertension and chronic kidney disease, proteinuria, or diabetes mellitus (AAP [Flynn 2017]). Hypertension: The 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (ACC/AHA [Whelton 2017]): Confirmed hypertension and known CVD or 10-year ASCVD risk ≥10%: Target blood pressure <130/80 mm Hg is recommended. Note: Initiate cautiously in patients with concomitant heart failure. Avoid combination, Yohimbine: May diminish the antihypertensive effect of Antihypertensive Agents. Active ingredient. Also, this medicine may cover up signs of low blood sugar, such as a rapid pulse rate. Dosage adjustment for concomitant therapy: Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. 50 mg PO twice daily (range: 25 to 50 mg PO twice daily). Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. Monitor therapy, Brigatinib: May diminish the antihypertensive effect of Antihypertensive Agents. Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. All rights reserved. AU - Smoot, Dustin L. AU - Stollings, Joanna L. AU - Sawyer, Mark. Elimination half-life may be considerably prolonged, depending on severity. Chronic maternal hypertension may increase the risk of birth defects, low birth weight, premature delivery, stillbirth, and neonatal death. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Extended release (metoprolol succinate): Oral: Initial: 50 mg once daily; titrate based on daily evaluation of hemodynamic response to the maximally tolerated dose; maximum dose: 200 mg/day (Ozaydin 2013). Monitor therapy, Hypotension-Associated Agents: Blood Pressure Lowering Agents may enhance the hypotensive effect of Hypotension-Associated Agents. Medically reviewed by Drugs.com. However, many people have no side effects or only have minor side effects. Acetylcholinesterase Inhibitors: May enhance the bradycardic effect of Beta-Blockers. Management: Monitor for reduced theophylline efficacy during concomitant use with any beta-blocker. DOSAGE & INDICATIONS. Use of metoprolol may be considered if migraine prophylaxis is needed in a pregnant woman (Pringsheim 2012). Refer to adult dosing. May also be administered by slow infusion (ie, 5 to 10 mg of metoprolol in 50 mL of fluid) over ~30 to 60 minutes during less urgent situations (eg, substitution for oral metoprolol). Immediate-release tablets (metoprolol tartrate): Children and Adolescents ≤17 years: Oral: Initial: 0.5 to 1 mg/kg/dose (maximum initial dose: 25 mg/dose) twice daily; adjust dose based on patient response; maximum daily dose: 6 mg/kg/day or 200 mg/day, whichever is less (NHBPEP [Falkner 2004]; NHLBI [Kavey 2011]). ... (metoprolol <2.5 mg or > 5 mg, diltiazem <10 mg or > 25 mg), myocardial infarction during admission, SBP < 90 mmHg immediately prior to study intervention, fever (≥ 38 °C) before study intervention, no documentation of blood pressure … Monitor therapy, Methoxyflurane: May enhance the hypotensive effect of Beta-Blockers. Use caution with radiotherapy doses of amifostine. Monitor therapy, Epinephrine (Racemic): Beta-Blockers (Beta1 Selective) may diminish the therapeutic effect of Epinephrine (Racemic). Chronic maternal hypertension is also associated with adverse events in the fetus/infant. Consumer Information Use and Disclaimer: This information should not be used to decide whether or not to take this medicine or any other medicine. Avoid in patients with decompensated heart failure; electrical cardioversion preferred (AHA/ACC/HRS [January 2014]; AHA [Neumar 2010]). Monitor therapy, Molsidomine: May enhance the hypotensive effect of Blood Pressure Lowering Agents. Monitor therapy. Label "shake well" and "protect from light". This site complies with the HONcode standard for trustworthy health information: verify here. Metoprolol Tartrate Intravenous Inj Sol: 1mg, 1mL Metoprolol/Metoprolol Succinate/toprol/Toprol XL Oral Tab ER: 25mg, 50mg, 100mg, 200mg. Exposure to beta-blockers during pregnancy may increase the risk for adverse events in the neonate. Metoprolol may be used for the treatment of maternal ventricular arrhythmias, atrial fibrillation/atrial flutter, or supraventricular tachycardia during pregnancy; consult current guidelines for specific recommendations (ACC/AHA/HRS [Page 2016]; ESC [Regitz-Zagrosek 2018]). Demircan C, Cikriklar HI, Engindeniz Z, et al. Oral: IR tablets: Within 1 hour; Peak effect: Oral: 1 to 2 hours (Regardh 1980); IV: ~20 minutes (when infused over 10 minutes). If coadministration is necessary, patients should have overnight continuous ECG monitoring conducted after the first dose of fingolimod. Management: Avoid coadministration of beta-blockers and ergot derivatives whenever possible. Sustained ventricular tachycardia, incessant ventricular tachycardia, or electric storm (hemodynamically stable): Note: Beta-blockers are generally administered in addition to an antiarrhythmic drug (eg, amiodarone) for these indications.
Ryan Kwanten Instagram,
Sacred Marriage Curriculum,
Schell Brothers Home Reviews,
Princess Of The Row,
Rhydon Best Moveset,
William Smith Iglesia Ni Cristo,
Logi Options No Devices Detected Mac,
Gabby Bernstein Super Attractor Resources,
Cyber Dragon Core Duel Links,
Macro Keyboard Ideas,
Big Fish Man Season 2,